You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
紅日藥業(300026.SZ)上半年預盈4.13億元-5.16億元 同比增長20%-50%
格隆匯 07-14 11:52

格隆匯7月14日丨紅日藥業(300026.SZ)披露2021年半年度業績預吿,公司預計2021年1-6月實現歸屬於上市公司股東的淨利潤4.13億元-5.16億元,同比增長20%-50%。

2021年半年度,在“數字紅日”戰略引領下,公司把握市場機遇,以市場為導向,積極適應國家政策,調整經營及營銷策略,加強資源配置與協同。報吿期內,公司主要業務中藥配方顆粒板塊和醫療器械板塊銷量呈持續增長態勢。同時,公司着力打造數字化企業,塑造新型能力,不斷加強品牌建設,堅持降本增效,取得了較好效果。

截止2021年6月30日,公司半年度非經營性損益金額約為1400.00萬元-1600.00萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account